{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:31:50Z","timestamp":1793943110385,"version":"4.8.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013276","name":"Interreg Europe","doi-asserted-by":"publisher","award":["IVA 5081"],"award-info":[{"award-number":["IVA 5081"]}],"id":[{"id":"10.13039\/100013276","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Exploratory Research in Clinical and Social Pharmacy"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.rcsop.2026.100833","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:54:13Z","timestamp":1787068453000},"page":"100833","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Characterising pharmacist interventions from person-centred medicines reviews in general practice settings"],"prefix":"10.1016","volume":"24","author":[{"given":"Ciara","family":"Kirke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J.","family":"Sahm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Moriarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Kinahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon","family":"O'Hagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma J.","family":"Coyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kieran","family":"Dalton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rcsop.2026.100833_bb0005","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12877-017-0621-2","article-title":"What is polypharmacy? A systematic review of definitions","volume":"17","author":"Masnoon","year":"2017","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.rcsop.2026.100833_bb0010","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000368191","article-title":"Temporal trends in polypharmacy and hyperpolypharmacy in older New Zealanders over a 9-year period: 2005\u20132013","volume":"61","author":"Nishtala","year":"2015","journal-title":"Gerontology"},{"key":"10.1016\/j.rcsop.2026.100833_bb0015","doi-asserted-by":"crossref","DOI":"10.1002\/pds.5880","article-title":"Prevalence of polypharmacy in elderly population worldwide: a systematic review and meta-analysis","volume":"33","author":"Wang","year":"2024","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.rcsop.2026.100833_bb0020","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s40264-015-0378-5","article-title":"Appropriate polypharmacy and medicine safety: when many is not too many","volume":"39","author":"Cadogan","year":"2016","journal-title":"Drug Saf"},{"key":"10.1016\/j.rcsop.2026.100833_bb0025","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f7033","article-title":"Polypharmacy: a necessary evil","volume":"347","author":"Wise","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.rcsop.2026.100833_bb0030","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/bcp.12995","article-title":"Potentially inappropriate prescribing according to STOPP and START and adverse outcomes in community-dwelling older people: a prospective cohort study","volume":"82","author":"Moriarty","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.rcsop.2026.100833_bb0035","article-title":"Prevalence of potentially inappropriate prescribing in older people in primary care and its association with hospital admission: longitudinal study","volume":"363","author":"P\u00e9rez","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.rcsop.2026.100833_bb0040","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.amjcard.2022.01.012","article-title":"Healthcare expenditure associated with polypharmacy in older adults with cardiovascular diseases","volume":"169","author":"Kwak","year":"2022","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.rcsop.2026.100833_bb0045","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12877-025-06545-w","article-title":"Polypharmacy and healthcare expenditures among older adults in the United States: a propensity score-matched study","volume":"26","author":"Pan","year":"2025","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.rcsop.2026.100833_bb0050","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s11096-013-9841-5","article-title":"Issues potentially affecting quality of life arising from long-term medicines use: a qualitative study","volume":"35","author":"Krska","year":"2013","journal-title":"Int J Clin Pharmacol"},{"key":"10.1016\/j.rcsop.2026.100833_bb0055","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/hex.12046","article-title":"Burden of treatment for chronic illness: a concept analysis and review of the literature","volume":"18","author":"Sav","year":"2015","journal-title":"Health Expect"},{"key":"10.1016\/j.rcsop.2026.100833_bb0060","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-036158","article-title":"Medication-related experiences of patients with polypharmacy: a systematic review of qualitative studies","volume":"10","author":"Eriksen","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.rcsop.2026.100833_bb0065","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-75888-8","article-title":"Polypharmacy, hospitalization, and mortality risk: a nationwide cohort study","volume":"10","author":"Chang","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.rcsop.2026.100833_bb0070","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/S0140-6736(17)31047-4","article-title":"Medication without harm: WHO\u2019S third global patient safety challenge","volume":"389","author":"Donaldson","year":"2017","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.rcsop.2026.100833_bb0075","doi-asserted-by":"crossref","DOI":"10.1007\/s11096-025-01971-7","article-title":"Pharmacists\u2019 role in interventions addressing excessive polypharmacy: a scoping review","author":"Ouraou","year":"2025","journal-title":"Int J Clin Pharmacol"},{"key":"10.1016\/j.rcsop.2026.100833_bb0080","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.sapharm.2019.04.010","article-title":"Community pharmacist led medication reviews in the UK: a scoping review of the medicines use review and the new medicine service literatures","volume":"16","author":"Stewart","year":"2020","journal-title":"Res Soc Adm Pharm"},{"key":"10.1016\/j.rcsop.2026.100833_bb0085","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12875-024-02457-7","article-title":"An exploration of Northern Ireland general practice pharmacists\u2019 views on their role in general practice: a cross-sectional survey","volume":"25","author":"Hassan","year":"2024","journal-title":"BMC Prim Care"},{"key":"10.1016\/j.rcsop.2026.100833_bb0090","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12875-022-01952-z","article-title":"The effectiveness and cost of integrating pharmacists within general practice to optimize prescribing and health outcomes in primary care patients with polypharmacy: a systematic review","volume":"24","author":"Croke","year":"2023","journal-title":"BMC Prim Care"},{"key":"10.1016\/j.rcsop.2026.100833_bb0095","doi-asserted-by":"crossref","first-page":"e665","DOI":"10.3399\/bjgp19X705461","article-title":"Impact of integrating pharmacists into primary care teams on health systems indicators: a systematic review","volume":"69","author":"Hayhoe","year":"2019","journal-title":"Br J Gen Pract J R Coll Gen Pract"},{"key":"10.1016\/j.rcsop.2026.100833_bb0100","doi-asserted-by":"crossref","DOI":"10.1177\/21501319251371825","article-title":"Implications derived from global experiences of barriers to integrating community pharmacists into primary healthcare: a scoping review","volume":"16","author":"Homayounifar","year":"2025","journal-title":"J Prim Care Community Health"},{"key":"10.1016\/j.rcsop.2026.100833_bb0105","series-title":"iSIMPATHY Evaluation Report","author":"Mair","year":"2023"},{"key":"10.1016\/j.rcsop.2026.100833_bb0110","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-008656","article-title":"Trends and interaction of polypharmacy and potentially inappropriate prescribing in primary care over 15 years in Ireland: a repeated cross-sectional study","volume":"5","author":"Moriarty","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.rcsop.2026.100833_bb0115","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s11096-024-01732-y","article-title":"Economic cost-benefit analysis of person-centred medicines reviews by general practice pharmacists","volume":"46","author":"O\u2019Mahony","year":"2024","journal-title":"Int J Clin Pharmacol"},{"key":"10.1016\/j.rcsop.2026.100833_bb0120","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1111\/bcp.16372","article-title":"Evaluating the impact of general practice pharmacist-led person-centred medicines reviews on medicines appropriateness and patient-reported outcome measures","volume":"91","author":"Kinahan","year":"2025","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.rcsop.2026.100833_bb0125","author":"Health Service Executive"},{"key":"10.1016\/j.rcsop.2026.100833_bb0130","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.japh.2019.07.008","article-title":"PaCIR: a tool to enhance pharmacist patient care intervention reporting","volume":"59","author":"Clay","year":"2019","journal-title":"J Am Pharm Assoc"},{"key":"10.1016\/j.rcsop.2026.100833_bb0135","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g1687","article-title":"Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide","volume":"348","author":"Hoffmann","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.rcsop.2026.100833_bb0140","author":"Scottish Government"},{"key":"10.1016\/j.rcsop.2026.100833_bb0145","series-title":"Polypharmacy Guidance, Realistic Prescribing 3rd Edition","author":"Scottish Government Polypharmacy Model of Care Group","year":"2018"},{"key":"10.1016\/j.rcsop.2026.100833_bb0150","author":"World Health Organization"},{"key":"10.1016\/j.rcsop.2026.100833_bb0155","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.2042-7174.1992.tb00556.x","article-title":"Assessing the quality of ward pharmacists\u2019 interventions","volume":"1","author":"Eadon","year":"1992","journal-title":"Int J Pharm Pract"},{"key":"10.1016\/j.rcsop.2026.100833_bb0160","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.japh.2017.06.002","article-title":"Association between polypharmacy and death: a systematic review and meta-analysis","volume":"57","author":"Leelakanok","year":"2017","journal-title":"J Am Pharm Assoc"},{"key":"10.1016\/j.rcsop.2026.100833_bb0165","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00228-017-2225-3","article-title":"Hospital admissions due to adverse drug reactions in the elderly. A meta-analysis","volume":"73","author":"Oscanoa","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.rcsop.2026.100833_bb0170","article-title":"Healthcare costs and health-related quality of life in older multimorbid patients after hospitalization","volume":"16","author":"Salari","year":"2023","journal-title":"Health Serv Insights"},{"key":"10.1016\/j.rcsop.2026.100833_bb0175","doi-asserted-by":"crossref","first-page":"3728","DOI":"10.3390\/jcm9113728","article-title":"The burden of potentially inappropriate medications in chronic polypharmacy","volume":"9","author":"Guillot","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.rcsop.2026.100833_bb0180","article-title":"Exploring pharmacists\u2019 perceptions of integrating pharmacists into the general practice setting","volume":"2","author":"Morcos","year":"2021","journal-title":"Explor Res Clin Soc Pharm"},{"key":"10.1016\/j.rcsop.2026.100833_bb0185","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.sapharm.2015.06.007","article-title":"Clinical medication review in Australia: a systematic review","volume":"12","author":"Jokanovic","year":"2016","journal-title":"Res Soc Adm Pharm"},{"key":"10.1016\/j.rcsop.2026.100833_bb0190","doi-asserted-by":"crossref","DOI":"10.4178\/epih.e2019020","article-title":"Impact of pharmacist-led home medicines review services on drug-related problems among the elderly population: a systematic review","volume":"41","author":"Gudi","year":"2019","journal-title":"Epidemiol Health"},{"key":"10.1016\/j.rcsop.2026.100833_bb0195","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s11096-012-9713-4","article-title":"Treatment related problems for outpatients with chronic diseases in Jordan: the value of home medication reviews","volume":"35","author":"Basheti","year":"2013","journal-title":"Int J Clin Pharmacol"},{"key":"10.1016\/j.rcsop.2026.100833_bb0200","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1111\/bcp.13640","article-title":"Patient involvement is essential in identifying drug-related problems","volume":"84","author":"Kari","year":"2018","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.rcsop.2026.100833_bb0205","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-035087","article-title":"Evaluation of the General Practice Pharmacist (GPP) intervention to optimise prescribing in Irish primary care: a non-randomised pilot study","volume":"10","author":"Cardwell","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.rcsop.2026.100833_bb0210","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s40266-012-0048-6","article-title":"The relationship between the extent of collaboration of general practitioners and pharmacists and the implementation of recommendations arising from medication review: a systematic review","volume":"30","author":"Kwint","year":"2013","journal-title":"Drugs Aging"},{"key":"10.1016\/j.rcsop.2026.100833_bb0215","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1186\/s12877-023-04256-8","article-title":"What makes a multidisciplinary medication review and deprescribing intervention for older people work well in primary care? A realist review and synthesis","volume":"23","author":"Radcliffe","year":"2023","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.rcsop.2026.100833_bb0220","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-036158","article-title":"Medication-related experiences of patients with polypharmacy: a systematic review of qualitative studies","volume":"10","author":"Eriksen","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.rcsop.2026.100833_bb0225","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejim.2016.12.021","article-title":"Deprescribing: a narrative review of the evidence and practical recommendations for recognizing opportunities and taking action","volume":"38","author":"Reeve","year":"2017","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.rcsop.2026.100833_bb0230","series-title":"Polypharmacy Guidance: Appropriate Prescribing Making Medicines Safe, Effective and Sustainable 2026\u20132029","author":"Scottish Government","year":"2026"},{"key":"10.1016\/j.rcsop.2026.100833_bb0235","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.jamda.2022.01.083","article-title":"Prevalence and risk factors for drug-related problems in people with dementia living in the community: a systematic review and meta-analysis","volume":"23","author":"Lau","year":"2022","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.rcsop.2026.100833_bb0240","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph19074313","article-title":"Drug-related problems and polypharmacy in nursing home residents: a cross-sectional study","volume":"19","author":"D\u00edez","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.rcsop.2026.100833_bb0245","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1071\/PY18022","article-title":"Pharmacists in general practice: recommendations resulting from team-based collaborative care","volume":"24","author":"Benson","year":"2018","journal-title":"Aust J Prim Health"},{"key":"10.1016\/j.rcsop.2026.100833_bb0250","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/ijpp\/riad061","article-title":"A pharmacist integrated into a general practice in Australia: an evolving model of care in medicines optimization","volume":"31","author":"Jordan","year":"2023","journal-title":"Int J Pharm Pract"},{"key":"10.1016\/j.rcsop.2026.100833_bb0255","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1007\/s11096-023-01604-x","article-title":"Evaluating the potential outcomes of pharmacist-led activities in the Australian general practice setting: a prospective observational study","volume":"45","author":"Sudeshika","year":"2023","journal-title":"Int J Clin Pharmacol"},{"key":"10.1016\/j.rcsop.2026.100833_bb0260","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/fampra\/cmab114","article-title":"General practitioners\u2019 views of pharmacist services in general practice: a qualitative evidence synthesis","volume":"39","author":"Hurley","year":"2022","journal-title":"Fam Pract"},{"key":"10.1016\/j.rcsop.2026.100833_bb0265","author":"Department of Health"},{"key":"10.1016\/j.rcsop.2026.100833_bb0270","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-081934","article-title":"Pharmacist-led primary care interventions to promote medicines optimisation and reduce overprescribing: a systematic review of UK studies and initiatives","volume":"14","author":"Chambers","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/j.rcsop.2026.100833_bb0275","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/bcp.14987","article-title":"Factors affecting physician implementation of hospital pharmacists\u2019 medication appropriateness recommendations in older adults","volume":"88","author":"Dalton","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.rcsop.2026.100833_bb0280","first-page":"98","article-title":"Outcomes of a pharmacist-led medication review programme for hospitalised elderly patients","volume":"24","author":"Chiu","year":"2018","journal-title":"Hong Kong Med J Xianggang Yi Xue Za Zhi"},{"key":"10.1016\/j.rcsop.2026.100833_bb0285","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1001\/archinternmed.2009.71","article-title":"A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial","volume":"169","author":"Gillespie","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.rcsop.2026.100833_bb0290","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1742-7843.2009.00511.x","article-title":"The effect of systematic medication review in elderly patients admitted to an acute ward of internal medicine","volume":"106","author":"Lisby","year":"2010","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.rcsop.2026.100833_bb0295","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/phar.1164","article-title":"Acceptance of recommendations by inpatient pharmacy case managers: unintended consequences of hospitalist and specialist care","volume":"33","author":"Anderegg","year":"2013","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.rcsop.2026.100833_bb0300","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12041320","article-title":"Which adverse events and which drugs are implicated in drug-related hospital admissions? A systematic review and meta-analysis","volume":"12","author":"Haerdtlein","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.rcsop.2026.100833_bb0305","article-title":"Adverse drug reactions in an ageing populaTion (ADAPT) study: prevalence and risk factors associated with adverse drug reaction-related hospital admissions in older patients","volume":"13","author":"Cahir","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.rcsop.2026.100833_bb0310","article-title":"Medication review in hospitalised patients to reduce morbidity and mortality","volume":"1","author":"B\u00fclow","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.rcsop.2026.100833_bb0315","first-page":"218","article-title":"Sustainability of medicine changes one year post iSIMPATHY medication review by a pharmacist independent prescriber","volume":"466","author":"Brown","year":"2026","journal-title":"Int J Clin Pharmacol"}],"container-title":["Exploratory Research in Clinical and Social Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667276626001319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667276626001319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:22:36Z","timestamp":1793942556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667276626001319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":63,"alternative-id":["S2667276626001319"],"URL":"https:\/\/doi.org\/10.1016\/j.rcsop.2026.100833","relation":{},"ISSN":["2667-2766"],"issn-type":[{"value":"2667-2766","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterising pharmacist interventions from person-centred medicines reviews in general practice settings","name":"articletitle","label":"Article Title"},{"value":"Exploratory Research in Clinical and Social Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rcsop.2026.100833","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100833"}}